The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Clinical Relevance of KRAS in Human Cancers
Open accessAbstract
The KRAS gene (Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) is an oncogene that encodes a small GTPase transductor protein called KRAS. KRAS is involved in the regulation of cell division as a result of its ability to relay external signals to the cell nucleus. Activating mutations in the KRAS gene impair the ability of the KRAS protein to switch between active and inactive states, leading to cell transformation and increased resistance to chemotherapy and biological therapies targeting epidermal growth factor receptors. This review highlights some of the features of the KRAS gene and the KRAS protein and summarizes current knowledge of the mechanism of KRAS gene regulation. It also underlines the importance of activating mutations in the KRAS gene in relation to carcinogenesis and their importance as diagnostic biomarkers, providing clues regarding human cancer patients' prognosis and indicating potential therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans
Reinhart, B. J., Slack, F. J., Basson, M., Pasquinelli, A. E., Bettinger, J. C., Rougvie, A. E., Horvitz, H. R., & Ruvkun, G. (2000) · Nature · doi:10.1038/35002607 · Cited by 4,981
Identification of Novel Genes Coding for Small Expressed RNAs
Lagos-Quintana, M., Rauhut, R., Lendeckel, W., & Tuschl, T. (2001) · Science · doi:10.1126/science.1064921 · Cited by 4,956
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
Barbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
Amado, R. G., Wolf, M., Peeters, M., Van Cutsem, E., Siena, S., Freeman, D. J., Juan, T., Sikorski, R., Suggs, S., Radinsky, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.7116 · Cited by 3,207 · cited 1×
“Progression-free survival of patients with wild-type versus mutant KRAS gene tumours was 12 versus seven weeks, while response rates obtained in another study were 17% versus 0% [118].”
Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)
Newton, C. R., Graham, A., Heptinstall, L. E., Powell, S. J., Summers, C., Kalsheker, N., Smith, J. C., & Markham, A. F. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.7.2503 · Cited by 2,475
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, T., Yatabe, Y., Nagino, M., Nimura, Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0637 · Cited by 2,354
Brennecke, J., Hipfner, D. R., Stark, A., Russell, R. B., & Cohen, S. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00231-9 · Cited by 2,042
Prevalence of ras gene mutations in human colorectal cancers
Bos, J. L., Fearon, E. R., Hamilton, S. R., Vries, M. V., van Boom, J. H., van der Eb, A. J., & Vogelstein, B. (1987) · Nature · doi:10.1038/327293a0 · Cited by 1,860
All ras proteins are polyisoprenylated but only some are palmitoylated
Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,799
Reduced accumulation of specific microRNAs in colorectal neoplasia.
Michael, M., Connor, S. M. O., Pellekaan, N. V. H., Young, G. P., & James, R. J. (2003) · PubMed · Cited by 1,775
Hyperactive Ras in developmental disorders and cancer
Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583
The Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its Loss in Oncogenic Ras Mutants
Scheffzek, K., Ahmadian, M. R., Kabsch, W., Wiesmüller, L., Lautwein, A., Schmitz, F., & Wittinghofer, A. (1997) · Science · doi:10.1126/science.277.5324.333 · Cited by 1,543 · cited 2×
“Mutation in codon 12 of the KRAS gene causes the encoded KRAS protein to “freeze” in its active state for a much longer duration than its nonmutated counterpart [11].”
BackgroundLai, E. C. (2002) · Nature Genetics · doi:10.1038/ng865 · Cited by 1,473
Eberhard, D. A., Johnson, B. E., Amler, L. C., Goddard, A. D., Heldens, S. L., Herbst, R. S., Ince, W. L., Jänne, P. A., Januario, T., Johnson, D. H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.857 · Cited by 1,461
Lièvre, A., Bachet, J.-B., Boige, V., Cayre, A., Le Corre, D., Buc, E., Ychou, M., Bouché, O., Landi, B., Louvet, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.5906 · Cited by 1,444
The Ras superfamily at a glance
Wennerberg, K., Rossman, K. L., & Der, C. J. (2005) · Journal of Cell Science · doi:10.1242/jcs.01660 · Cited by 1,352
The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website
Bamford, S., Dawson, E., Forbes, S., Clements, J., Pettett, R., Dogan, A., Flanagan, A., Teague, J., Futreal, P. A., Stratton, M. R., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601894 · Cited by 1,267
Detection of high incidence of K-ras oncogenes during human colon tumorigenesis
Forrester, K., Almoguera, C., Han, K., Grizzle, W. E., & Perucho, M. (1987) · Nature · doi:10.1038/327298a0 · Cited by 1,061
Cogoi, S., & Xodo, L. E. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl286 · Cited by 739
Hruban, R. H., van Mansfeld, A. D. M., Offerhaus, G. J. A., van Weering, D. H. J., Allison, D. C., Goodman, S. N., Kensler, T. W., Bose, K., Cameron, J. L., & Bos, J. L. (1993) · PubMed Central · Cited by 650
Massarelli, E., Varella-Garcia, M., Tang, X., Xavier, A. C., Ozburn, N. C., Liu, D. D., Bekele, B. N., Herbst, R. S., & Wistuba, I. I. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3043 · Cited by 597
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
Guerra, C., Mijimolle, N., Dhawahir, A., Dubus, P., Barradas, M., Serrano, M., Campuzano, V., & Barbacid, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00191-0 · Cited by 571
Sensitive Sequencing Method for KRAS Mutation Detection by Pyrosequencing
Ogino, S., Kawasaki, T., Brahmandam, M., Yan, L., Cantor, M., Namgyal, C., Mino-Kenudson, M., Lauwers, G. Y., Loda, M., & Fuchs, C. S. (2005) · The Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60571-5 · Cited by 486
Ras oncogenes and their downstream targets
Rajalingam, K., Schreck, R., Rapp, U. R., & Albert, Š. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.01.012 · Cited by 458
Ahrendt, S. A., Decker, P. A., Alawi, E. A., Zhu, Y.-R., Sanchez-Cespedes, M., Yang, S. C., Haasler, G. B., Kajdacsy-Balla, A., Demeure, M. J., & Sidransky, D. (2001) · Cancer · doi:10.1002/1097-0142(20010915)92:6<1525::aid-cncr1478>3.0.co;2-h · Cited by 449
Tam, I. Y. S., Chung, L. P., Suen, W. S., Wang, E., Wong, M. C. M., Ho, K. K., Lam, W. K., Chiu, S. W., Girard, L., Minna, J. D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1981 · Cited by 400
Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene
McGrath, J. P., Capon, D. J., Smith, D. H., Chen, E. Y., Seeburg, P. H., Goeddel, D. V., & Levinson, A. D. (1983) · Nature · doi:10.1038/304501a0 · Cited by 357
Samowitz, W. S., Curtin, K., Schaffer, D., Robertson, M. A., Leppert, M., & Slattery, M. L. (2000) · PubMed · Cited by 351
The Tumor Suppressor Protein p16INK4a
SERRANO, M. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3824 · Cited by 346
Mode of action and application of Scorpion primers to mutation detection
Thelwell, N. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.19.3752 · Cited by 337
Chang, E. H., Gonda, M. A., Ellis, R. W., Scolnick, E. M., & Lowy, D. R. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.16.4848 · Cited by 322
Phosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell Lines
Hollestelle, A., Elstrodt, F., Nagel, J. H. A., Kallemeijn, W. W., & Schutte, M. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0263 · Cited by 320
Wildtype Kras2 can inhibit lung carcinogenesis in mice
Zhang, Z., Wang, Y., Vikis, H. G., Johnson, L., Liu, G., Li, J., Anderson, M. W., Sills, R. C., Hong, H. L., Devereux, T. R., et al. (2001) · Nature Genetics · doi:10.1038/ng721 · Cited by 296
A genome-wide survey of RAS transformation targets
Zuber, J., Tchernitsa, O. I., Hinzmann, B., Schmitz, A.-C., Grips, M., Hellriegel, M., Sers, C., Rosenthal, A., & Schäfer, R. (2000) · Nature Genetics · doi:10.1038/72799 · Cited by 294
Gideon, P., John, J., Frech, M., Lautwein, A., Clark, R., Scheffler, J. E., & Wittinghofer, A. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.5.2050 · Cited by 287
Development of Farnesyl Transferase Inhibitors: A Review
Appels, N. M. G. M., Beijnen, J. H., & Schellens, J. H. M. (2005) · The Oncologist · doi:10.1634/theoncologist.10-8-565 · Cited by 272
The KRAS oncogene: Past, present, and future
Kranenburg, O. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.10.001 · Cited by 252
ras oncogenes: their role in neoplasia
BARBACID, M. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb01848.x · Cited by 242
Carta, C., Pantaleoni, F., Bocchinfuso, G., Stella, L., Vasta, I., Sarkozy, A., Digilio, C., Palleschi, A., Pizzuti, A., Grammatico, P., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/504394 · Cited by 225
Characterization of a human colon/lung carcinoma oncogene
McCoy, M. S., Toole, J. J., Cunningham, J. M., Chang, E. H., Lowy, D. R., & Weinberg, R. A. (1983) · Nature · doi:10.1038/302079a0 · Cited by 207
Hurwitz, H., & Saini, S. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.08.001 · Cited by 179
Hotta, K., Kiura, K., Ueoka, H., Tabata, M., Fujiwara, K., Kozuki, T., Okada, T., Hisamoto, A., & Tanimoto, M. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.04.036 · Cited by 176
Structure of small G proteins and their regulators.
Paduch, M., Jeleń, F., & Otlewski, J. (2001) · Acta Biochimica Polonica · doi:10.18388/abp.2001_3850 · Cited by 173
Huncharek, M. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1507 · Cited by 172
Targeting mutations in solid tumors: Scientific rationale and novel therapeutic options
DEMETRI, G. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90099-5 · Cited by 169
Der, C. J., & Cooper, G. M. (1983) · Cell · doi:10.1016/0092-8674(83)90510-x · Cited by 167
Role of proto-oncogene activation in carcinogenesis.
Anderson, M. W., Reynolds, S. H., You, M., & Maronpot, R. M. (1992) · Environmental Health Perspectives · doi:10.1289/ehp.929813 · Cited by 161
Fivaz, M., & Meyer, T. (2005) · Journal of Cell Biology · doi:10.1083/jcb.200409157 · Cited by 154
Tam, W., Hughes, S. H., Hayward, W. S., & Besmer, P. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4275-4286.2002 · Cited by 151
Sugio, K., Uramoto, H., Ono, K., Oyama, T., Hanagiri, T., Sugaya, M., Ichiki, Y., So, T., Nakata, S., Morita, M., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603040 · Cited by 147
Al‐Mulla, F., Going, J. J., Sowden, E., Winter, A., Pickford, I. R., & Birnie, G. D. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199806)185:2<130::aid-path85>3.0.co;2-m · Cited by 122
Farnesyltransferase Inhibitors: A Detailed Chemical View on an Elusive Biological Problem
Sousa, S. F., Fernandes, P. A., & Ramos, M. J. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708784638825 · Cited by 121
Park, J., Strock, C. J., Ball, D. W., & Nelkin, B. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.543-554.2003 · Cited by 119
The ras Oncogenes in Human Lung Cancer
Rodenhuis, S., & Slebos, R. J. C. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.6_pt_2.s27 · Cited by 118
Prenylation-dependent Association of Ki-Ras with Microtubules
Thissen, J., Gross, J. M., Subramanian, K., Meyer, T., & Casey, P. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30362 · Cited by 117
Mutation scanning using high-resolution melting
Taylor, C. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370433 · Cited by 115
Grana, T. M., Rusyn, E. V., Zhou, H., Sartor, C. I., & Cox, A. D. (2002) · PubMed · Cited by 114
Sharma, A. K. (2011) · Cited by 113
The status and role of ErbB receptors in human cancer
Überall, I., Kolář, Z., Trojanec, R., Berkovcová, J., & Hajdúch, M. (2008) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2007.12.002 · Cited by 107
Self-citationHegi, M. E., Devereux, T. R., Dietrich, W. F., Cochran, C., Lander, E. S., Foley, J. F., Maronpot, R. R., Anderson, M. W., & Wiseman, R. W. (1994) · PubMed · Cited by 101
Giusti, R. M., Shastri, K. A., Pilaro, A. M., Fuchs, C., Cordoba-Rodriguez, R., Koti, K. M., Rothmann, M. D., Men, A. Y., Zhao, H., Hughes, M., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1354 · Cited by 101
Zou, H., Taylor, W. R., Harrington, J. J., Hussain, F. T. N., Cao, X., Loprinzi, C. L., Levine, T. R., Rex, D. K., Ahnen, D. J., Knigge, K. L., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.023 · Cited by 97
Jean, G. W., & Shah, S. R. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.6.742 · Cited by 96
Regional chromosomal localization of N-ras, K-ras-1, K-ras-2 andmyboncogenes in human cells
McBride, O. W., Swan, D. C., Tronick, S. R., Gol, R., Klimanis, D., Moore, D. E., & Aaronson, S. A. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.23.8221 · Cited by 93
Recent advances of novel targeted therapy in non-small cell lung cancer
Katzel, J. A., Fanucchi, M. P., & Li, Z. (2009) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-2-2 · Cited by 88
Bazan, V., Agnese, V., Corsale, S., Calò, V., Valerio, M. R., Latteri, M. A., Vieni, S., Grassi, N., Cicero, G., Dardanoni, G., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi908 · Cited by 84
Chromosomal localization of three humanras genes by in situ molecular hybridization
Popescu, N. C., Amsbaugh, S. C., DiPaolo, J. A., Tronick, S. R., Aaronson, S. A., & Swan, D. C. (1985) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01534703 · Cited by 81
Porta, M. S., Malats, N., Guarner, L., Carrato, A., Rifà, J., Salas, A., Corominas, J. M., Andreu, M. G., & Real, F. X. (1999) · Journal of Epidemiology & Community Health · doi:10.1136/jech.53.11.702 · Cited by 77
Lim, E. H., Zhang, S.-L., Li, J., Yap, W. S., Howe, T.-C., Tan, B. P., Lee, Y.-S., Wong, D., Khoo, K., Seto, K., et al. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181913e28 · Cited by 77
Clayton, S. J., Scott, F., Walker, J., Callaghan, K., Haque, K., Liloglou, T., Xinarianos, G., Shawcross, S., Ceuppens, P., Field, J. K., et al. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.12.1929 · Cited by 77
How does p21ras transform cells?
Marshall, C. J. (1991) · Trends in Genetics · doi:10.1016/0168-9525(91)90278-x · Cited by 75
Gefitinib in non-small cell lung cancer
Tamura, K., & Fukuoka, M. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.6.985 · Cited by 75
K-Ras Regulates the Steady-state Expression of Matrix Metalloproteinase 2 in Fibroblasts
Liao, J., Wolfman, J. C., & Wolfman, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301931200 · Cited by 71
Laghi, L., Orbetegli, O., Bianchi, P. P., Zerbi, A., Carlo, V. D., Boland, C. R., & Malesci, A. (2002) · Oncogene · doi:10.1038/sj.onc.1205533 · Cited by 71
Presence of a Kirsten Murine Sarcoma Virus ras Oncogene in Cells Transformed by 3-Methylcholanthrene
Parada, L. F., & Weinberg, R. A. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.12.2298 · Cited by 70
COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing
Li, J., & Makrigiorgos, G. M. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370427 · Cited by 69
Beau‐Faller, M., Legrain, M., Voegeli, A.-C., Guérin, É., Lavaux, T., Ruppert, A.-M., Neuville, A., Massard, G., Wihlm, J.-M., Quoix, É., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604925 · Cited by 59
LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer
Li, J., Zhang, Z., Zunyan Dai, Y., Plass, C., Morris, Q., Wang, Y., Wiest, J. S., Anderson, M. W., & You, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206192 · Cited by 58
Electron microscopic imaging of Ras signaling domains
Hancock, J. F., & Prior, I. A. (2005) · Methods · doi:10.1016/j.ymeth.2005.05.018 · Cited by 56
Ikeda, N., Nakajima, Y., Sho, M., Adachi, M., Huang, C., Iki, K., Kanehiro, H., Hisanaga, M., Nakano, H., & Miyake, M. (2001) · Cancer · doi:10.1002/1097-0142(20010801)92:3<488::aid-cncr1347>3.0.co;2-f · Cited by 54
Trimodality treatment in Stage III nonsmall cell lung carcinoma
Broermann, P., Junker, K., Brandt, B., et al. (2002) · Cancer · doi:10.1002/cncr.10387 · Cited by 54
Zhang, Z., Jiang, G., Yang, F., & Wang, J. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.11.3297 · Cited by 54
Escandell, J. M., Kaler, P., Recio, M. C., Sasazuki, T., Shirasawa, S., Augenlicht, L. H., Rı́os, J.-L., & Klampfer, L. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.05.004 · Cited by 52
Amicarelli, G., Shehi, E., Makrigiorgos, G. M., & Adlerstein, D. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm809 · Cited by 50
Yan, Z., Deng, X., Chen, M., Xu, Y., Ahram, M. A., Sloane, B. F., & Friedman, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27902 · Cited by 49
Samouëlian, V., Maugard, C. M., Jolicoeur, M., Bertrand, R., Arcand, S. L., Tonin, P. N., Provencher, D. M., & Mes‐Masson, A. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0843-9 · Cited by 49
Downward, J. (2003) · Biochemical Journal · doi:10.1042/bj20031745 · Cited by 45
Moul, J. W., Theune, S. M., & Chang, E. H. (1992) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870050204 · Cited by 44
Ross, P. J., George, M. L., Cunningham, D., Di-Stefano, F., Andreyev, J. N., Workman, P., & Clarke, P. A. (2001) · PubMed · Cited by 41
Rapid Screening Assay for KRAS Mutations by the Modified Smart Amplification Process
Tatsumi, K., Mitani, Y., Watanabe, J., Takakura, H., Hoshi, K., Kawai, Y., Kikuchi, T., Kogo, Y., Oguchi-Katayama, A., Tomaru, Y., et al. (2008) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.080024 · Cited by 40
An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia
Agarwal, A., Eide, C. A., Harlow, A., Corbin, A. S., Mauro, M. J., Druker, B. J., Corless, C. L., Heinrich, M. C., & Deininger, M. W. (2008) · Leukemia · doi:10.1038/leu.2008.124 · Cited by 36
Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer
Morales, E., Porta, M. S., Vioqué, J., López‐Jiménez, T., Mendez, M. A., Pumarega, J. A., Malats, N., Crous‐Bou, M., Ngo, J., Rifà, J., et al. (2007) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2007.060632 · Cited by 32
Chronic myeloid leukaemia: the evolution of gene‐targeted therapy
Joske, D. J. L. (2008) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb02027.x · Cited by 25
Bentivegna, S., Zheng, J., Namsaraev, E. A., Carlton, V. E. H., Pavlı́ček, A., Moorhead, M., Siddiqui, F. A., Wang, Z., Lee, L., Ireland, J. S., et al. (2008) · Human Mutation · doi:10.1002/humu.20672 · Cited by 24
Wei, S., Liang, Z., Gao, J., Wu, S., Hong, Z., Liu, H., & Liu, T. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03542.x · Cited by 24
Hann, C. L., & Brahmer, J. R. (2007) · Current Treatment Options in Oncology · doi:10.1007/s11864-007-0024-2 · Cited by 19
Bian, Y., Matsubayashi, H., Li, C., Abe, T., Canto, M. I., Murphy, K. M., & Goggins, M. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.10.3453 · Cited by 19
Simplified reverse dot blot analyses for detecting ras oncogene mutations
Albitar, M. X., WU, W., FELTZ, E., et al. (1997) · Molecular Diagnosis · doi:10.1016/s1084-8592(97)80025-2 · Cited by 13
Amicarelli, G., Adlerstein, D., Shehi, E., Wang, F., & Makrigiorgos, G. M. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.068817 · Cited by 12
Yanagihara, M., Ishikawa, S., Naito, M., Nakajima, J., Aburatani, H., & Hatakeyama, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208736 · Cited by 9
Potential Clinical Application of Antioncogene Ribozymes for Human Lung Cancer
Tong, A. W., Zhang, Y., Cunningham, C. C., Maples, P. B., & Nemunaitis, J. J. (2001) · Clinical Lung Cancer · doi:10.3816/clc.2001.n.007 · Cited by 8
p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
Cited by
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Zhong, L., Li, Y., Xiong, L., Wang, W., Wu, M., Yuan, T., Yang, W., Tian, C., Miao, Z., Wang, T., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00572-w · Cited by 1,696
Targeting the untargetable KRAS in cancer therapy
Liu, P., Wang, Y., & Li, X. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.03.002 · Cited by 366
CA 19-9: Biochemical and Clinical Aspects
Scarà, S., Bottoni, P., & Scatena, R. (2015) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-017-7215-0_15 · Cited by 351
Liu, C., Zheng, S., Jin, R., Wang, X., Wang, F., Zang, R., Xu, H., Lu, Z., Huang, J., Lei, Y., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.10.027 · Cited by 281
KRAS: From undruggable to a druggable Cancer Target
Uprety, D., & Adjei, A. A. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102070 · Cited by 271
Metadata
- Authors
- Jančík, S., Drábek, J., Radzioch, D., & Hajdúch, M.
- Venue
- Journal of Biomedicine and Biotechnology
- Publisher
- Wiley
- Published
- 2010
- Volume
- 2010
- Pages
- 1-13
- ISSN
- 1110-7243 (ISSN-L)
- 1110-7251
- OpenAlex
- W1973740519
- Cited by
- 402
- References
- 109
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.